Alivus Life Sciences Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Dec 2025 is 14.44% vs -2.30% in Sep 2025

Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is 15.56% vs 6.99% in Sep 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is 29.08% vs 3.98% in Sep 2025

Interest

QoQ Growth in quarter ended Dec 2025 is 12.88% vs 5.60% in Sep 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

Compare Quarterly Results Of Alivus Life With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

672.89

247.06

425.83

172.36%

Other Operating Income

0.00

Total Operating income

672.89

247.06

425.83

172.36%

Raw Material Cost

276.36

57.30

219.06

382.30%

Purchase of Finished goods

0.00

13.65

-13.65

-100.00%

(Increase) / Decrease In Stocks

0.06

-21.93

21.99

100.27%

Employee Cost

66.37

43.18

23.19

53.71%

Power Cost

0.00

28.53

-28.53

-100.00%

Manufacturing Expenses

0.00

-0.01

0.01

100.00%

Selling and Distribution Expenses

0.00

Other Expenses

98.82

35.80

63.02

176.03%

Total Expenditure (Excl Depreciation)

441.61

156.52

285.09

182.14%

Operating Profit (PBDIT) excl Other Income

231.28

90.54

140.74

155.45%

Other Income

13.93

13.43

0.50

3.72%

Operating Profit (PBDIT)

245.21

103.97

141.24

135.85%

Interest

1.49

0.06

1.43

2,383.33%

Exceptional Items

-25.66

0.00

-25.66

Gross Profit (PBDT)

218.06

103.91

114.15

109.85%

Depreciation

19.66

18.39

1.27

6.91%

Profit Before Tax

198.39

85.52

112.87

131.98%

Tax

48.13

22.62

25.51

112.78%

Provisions and contingencies

0.00

Profit After Tax

150.26

62.90

87.36

138.89%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

150.26

62.90

87.36

138.89%

Equity Capital

24.54

10.46

14.08

134.61%

Face Value

2.00

1.00

0.00

Reserves

0.00

Earnings per share (EPS)

12.25

6.01

6.24

103.83%

Diluted Earnings per share

12.22

6.01

6.21

103.33%

Operating Profit Margin (Excl OI)

34.37%

36.65%

0.00

-2.28%

Gross Profit Margin

32.41%

42.06%

0.00

-9.65%

PAT Margin

22.33%

25.46%

0.00

-3.13%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 672.89 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 14.44% vs -2.30% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 4.84% vs 12.05% in Dec 2024

Quarterly - Standalone Net Profit

Standalone Net Profit 150.26 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 15.56% vs 6.99% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 9.71% vs 15.32% in Dec 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 231.28 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 29.08% vs 3.98% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 21.53% vs 10.29% in Dec 2024

Quarterly - Interest

Interest 1.49 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 12.88% vs 5.60% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 223.91% vs 17.95% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 34.37%

in Dec 2025

Figures in %

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024